Skip to main content
PMC home page
American Journal of Public Health logoLink to American Journal of Public Health
. 1988 Jun;78(6):623–624. doi: 10.2105/ajph.78.6.623

"Hypertensive emergency": a useful diagnostic category.

R B Hickler 1
PMCID: PMC1350270  PMID: 3369590

Full text

PDF
623

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BYROM F. B. The pathogenesis of hypertensive encephalopathy and its relation to the malignant phase of hypertension; experimental evidence from the hypertensive rat. Lancet. 1954 Jul 31;267(6831):201–211. doi: 10.1016/s0140-6736(54)91821-8. [DOI] [PubMed] [Google Scholar]
  2. Bennett N. M., Shea S. Hypertensive emergency: case criteria, sociodemographic profile, and previous care of 100 cases. Am J Public Health. 1988 Jun;78(6):636–640. doi: 10.2105/ajph.78.6.636. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Brown J. J., Davies D. L., Lever A. F., Robertson J. I. Plasma Renin Concentration in Human Hypertension-III: Renin in Relation to Complications of Hypertension. Br Med J. 1966 Feb 26;1(5486):505–508. doi: 10.1136/bmj.1.5486.505. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bulpitt C. J. Prognosis of treated hypertension 1951-1981. Br J Clin Pharmacol. 1982 Jan;13(1):73–79. doi: 10.1111/j.1365-2125.1982.tb01340.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Chester E. M., Agamanolis D. P., Banker B. Q., Victor M. Hypertensive encephalopathy: a clinicopathologic study of 20 cases. Neurology. 1978 Sep;28(9 Pt 1):928–939. doi: 10.1212/wnl.28.9.928. [DOI] [PubMed] [Google Scholar]
  6. Gudbrandsson T., Hansson L., Herlitz H., Andrén L. Malignant hypertension--improving prognosis in a rare disease. Acta Med Scand. 1979;206(6):495–499. doi: 10.1111/j.0954-6820.1979.tb13553.x. [DOI] [PubMed] [Google Scholar]
  7. Hayreh S. S., Servais G. E., Virdi P. S. Fundus lesions in malignant hypertension. IV. Focal intraretinal periarteriolar transudates. Ophthalmology. 1986 Jan;93(1):60–73. doi: 10.1016/s0161-6420(86)33774-6. [DOI] [PubMed] [Google Scholar]
  8. Hayreh S. S., Servais G. E., Virdi P. S. Fundus lesions in malignant hypertension. V. Hypertensive optic neuropathy. Ophthalmology. 1986 Jan;93(1):74–87. doi: 10.1016/s0161-6420(86)33773-4. [DOI] [PubMed] [Google Scholar]
  9. Hayreh S. S., Servais G. E., Virdi P. S., Marcus M. L., Rojas P., Woolson R. F. Fundus lesions in malignant hypertension. III. Arterial blood pressure, biochemical, and fundus changes. Ophthalmology. 1986 Jan;93(1):45–59. doi: 10.1016/s0161-6420(86)33775-8. [DOI] [PubMed] [Google Scholar]
  10. Isles C., Brown J. J., Cumming A. M., Lever A. F., McAreavey D., Robertson J. I., Hawthorne V. M., Stewart G. M., Robertson J. W., Wapshaw J. Excess smoking in malignant-phase hypertension. Br Med J. 1979 Mar 3;1(6163):579–581. doi: 10.1136/bmj.1.6163.579. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. KAPLAN N. M. PRIMARY ALDOSTERONISM WITH MALIGNANT HYPERTENSION. N Engl J Med. 1963 Dec 12;269:1282–1286. doi: 10.1056/NEJM196312122692403. [DOI] [PubMed] [Google Scholar]
  12. KINCAID-SMITH P., McMICHAEL J., MURPHY E. A. The clinical course and pathology of hypertension with papilloedema (malignant hypertension). Q J Med. 1958 Jan;27(105):117–153. [PubMed] [Google Scholar]
  13. Kincaid-Smith P. Malignant hypertension: mechanisms and management. Pharmacol Ther. 1980;9(2):245–269. doi: 10.1016/s0163-7258(80)80021-0. [DOI] [PubMed] [Google Scholar]
  14. Kincaid-Smith P. Understanding malignant hypertension. Aust N Z J Med. 1981;11(Suppl 1):64–68. [PubMed] [Google Scholar]
  15. Koch-Weser J. Hypertensive emergencies. N Engl J Med. 1974 Jan 24;290(4):211–214. doi: 10.1056/NEJM197401242900407. [DOI] [PubMed] [Google Scholar]
  16. Mandal A. K., Bell R. D., Nordquist J. A., Lindeman R. D. Anatomic pathology and pathogenesis of the lesions of small arteries and arterioles of the kidney in essential hypertension. Pathol Annu. 1977;12(Pt 1):331–371. [PubMed] [Google Scholar]
  17. McGregor E., Isles C. G., Jay J. L., Lever A. F., Murray G. D. Retinal changes in malignant hypertension. Br Med J (Clin Res Ed) 1986 Jan 25;292(6515):233–234. doi: 10.1136/bmj.292.6515.233. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. PERERA G. A. Hypertensive vascular disease; description and natural history. J Chronic Dis. 1955 Jan;1(1):33–42. doi: 10.1016/0021-9681(55)90019-9. [DOI] [PubMed] [Google Scholar]
  19. PERERA G. A. The accelerated form of hypertension: a unique entity. Trans Assoc Am Physicians. 1958;71:62–68. [PubMed] [Google Scholar]
  20. Petitti D. B., Klatsky A. L. Malignant hypertension in women aged 15 to 44 years and its relation to cigarette smoking and oral contraceptives. Am J Cardiol. 1983 Aug;52(3):297–298. doi: 10.1016/0002-9149(83)90126-1. [DOI] [PubMed] [Google Scholar]
  21. Yu S. H., Whitworth J. A., Kincaid-Smith P. S. Malignant hypertension: aetiology and outcome in 83 patients. Clin Exp Hypertens A. 1986;8(7):1211–1230. doi: 10.3109/10641968609045483. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Public Health are provided here courtesy of American Public Health Association

RESOURCES